Search Results - "Kimak, M A"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Hereditary Lymphedema: Evidence for Linkage and Genetic Heterogeneity by Ferrell, Robert E., Levinson, Kara L., Esman, Judith H., Kimak, Mark A., Lawrence, Elizabeth C., Michael Barmada, M., Finegold, David N.

    Published in Human molecular genetics (01-12-1998)
    “…Hereditary or primary lymphedema is a developmental disorder of the lymphatic system which leads to a disabling and disfiguring swelling of the extremities…”
    Get full text
    Journal Article
  2. 2

    Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema by Ferrell, Robert E, Karkkainen, Marika J, Lawrence, Elizabeth C, Kimak, Mark A, Levinson, Kara L, McTigue, Michele A, Alitalo, Kari, Finegold, David N

    Published in Nature genetics (01-06-2000)
    “…Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to…”
    Get full text
    Journal Article
  3. 3

    Truncating mutations in FOXC2 cause multiple lymphedema syndromes by FINEGOLD, David N, KIMAK, Mark A, LAWRENCE, Elizabeth C, LEVINSON, Kara L, CHERNISKE, Elizabeth M, POBER, Barbara R, DUNLAP, Jean W, FERRELL, Robert E

    Published in Human molecular genetics (15-05-2001)
    “…Hereditary lymphedemas are developmental disorders of the lymphatics resulting in edema of the extremities due to altered lymphatic flow. One such disorder,…”
    Get full text
    Journal Article
  4. 4

    VEGFR3 gene structure, regulatory region, and sequence polymorphisms by Iljin, K, Karkkainen, M J, Lawrence, E C, Kimak, M A, Uutela, M, Taipale, J, Pajusola, K, Alhonen, L, Halmekytö, M, Finegold, D N, Ferrell, R E, Alitalo, K

    Published in The FASEB journal (01-04-2001)
    “…Vascular endothelial growth factor receptor 3 (VEGFR-3) is required for cardiovascular development during embryogenesis. In adults, this receptor is expressed…”
    Get full text
    Journal Article
  5. 5

    Energy requirements for diphtheria toxin translocation are coupled to the maintenance of a plasma membrane potential and a proton gradient by Hudson, T H, Scharff, J, Kimak, M A, Neville, D M

    Published in The Journal of biological chemistry (05-04-1988)
    “…Translocation of diphtheria toxin (DT) or ricin to the cytosol is the rate-limiting step responsible for (pseudo) first-order decline in protein synthesis…”
    Get full text
    Journal Article
  6. 6

    PI-10 by Feng, Y., Pollock, B. G., Ferrell, R. E., Kimak, M. A., Reynolds, C., Bies, R. R.

    Published in Clinical pharmacology and therapeutics (01-02-2006)
    “…AIM To develop a population pharmacokinetic (PK) model using sparse data sampling from a geriatric depressed population with five‐year paroxetine treatment and…”
    Get full text
    Journal Article
  7. 7

    Paroxetine: population pharmacokinetic analysis in late‐life depression using sparse concentration sampling by Feng, Yan, Pollock, Bruce G., Ferrell, Robert E., Kimak, Mark A., Iii, Charles F. Reynolds, Bies, Robert R.

    Published in British journal of clinical pharmacology (01-05-2006)
    “…Aim To develop a population pharmacokinetic (PK) model using sparse sampling of long‐term treatment with paroxetine in elderly depressed subjects,…”
    Get full text
    Journal Article
  8. 8

    Lymphedema-distichiasis syndrome and FOXC2 gene mutation by Traboulsi, Elias I, Al-Khayer, Khouloud, Matsumoto, Masayuki, Kimak, Mark A, Crowe, Susan, Wilson, Steven E, Finegold, David N, Ferrell, Robert E, Meisler, David M

    Published in American journal of ophthalmology (01-10-2002)
    “…PURPOSE: To describe the clinical characteristics of a family with autosomal dominant lymphedema-distichiasis syndrome and to report the results of analysis of…”
    Get full text
    Journal Article